NEW YORK, Jan. 27, 2025 (GLOBE NEWSWIRE) -- At the end of the settlement date of January 15, 2025, short interest in 3,099 Nasdaq Global MarketSM securities totaled 12,402,417,655 shares compared with 12,137,206,474 shares in 3,085 Global Market issues reported for the prior settlement date of December 31, 2024. The mid-January short interest represents 2.56 days compared with 2.50 days for the prior reporting period. Short interest in 1,635 securities on The Nasdaq Capital MarketSM totaled 2,424,890,788 sh ...

About this content About Josh Lamb After graduating from the University of Kent in the summer of 2022 with a degree in History, Josh joined Proactive later that year as a journalist in the UK editorial team. Josh has reported on a range of areas whilst at Proactive, including energy companies during a time of global crisis, aviation and airlines as the sector recovers from the pandemic, as well as covering economic, social and governance issues. Read more About the publisher Proactive financial news and ...

Nasdaq, Inc. (NDAQ) is slated to report fourth-quarter 2024 earnings on Jan. 29, before the opening bell. The company delivered an earnings surprise in three of the last four reported quarters while missing in one.See the Zacks Earnings Calendar to stay ahead of market-making news.Factors to ConsiderContinued organic revenue growth, new sales, an increase in Financial Crime Management Technology revenues and contributions from the Adenza acquisition are likely to have aided Nasdaq’s fourth-quarter performan ...

BEIJING, China, Jan. 23, 2025 (GLOBE NEWSWIRE) -- TuanChe Limited (“TuanChe,” “Company,” “we,” or “our”) (NASDAQ: TC), a leading automotive marketplace platform in China, announced today that on January 16, 2025, it received two notification letters from the Nasdaq Listing Qualifications Staff of The NASDAQ Stock Market LLC (“Nasdaq”). The letters notified the Company of its non-compliance with the annual meeting requirement and the minimum stockholders’ equity requirement, as outlined in the Nasdaq Listing ...

Company Performance - Shares of Grail surged 20% intraday, making it the biggest gainer in the Nasdaq 100 index [1] - Grail shares had been little changed since the company's June split from Illumina until soaring Wednesday [3] Financial Projections - Grail projected fiscal 2024 revenue of $124 million to $126 million [3] - The company expects fiscal 2025 U.S. sales of its Galleri blood test to rise 20% to 30% year-over-year [3][4] - Grail expects to burn through less than $320 million over fiscal 2025 [3] - The company has $767 million cash on hand to end 2024, providing runway into 2028 [3] Business Background - Grail was spun off from Illumina Health following legal battles with regulators and started trading on its own last June [2] - The company is developing a number of early detection cancer screening tests [2][4] Market Position - Grail's stock performance surpassed Arm Holdings (ARM) and Netflix (NFLX) in recent trading [1]

Nasdaq (NDAQ) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2024. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on January 29. O ...

EnglishItalianoEspañolPortuguêsDeutschالعربيةFrançaisImportant DisclaimersThe content provided on the website includes general news and publications, our personal analysis and opinions, and contents provided by third parties, which are intended for educational and research purposes only. It does not constitute, and should not be read as, any recommendation or advice to take any action whatsoever, including to make any investment or buy any product. When making any financial decision, you should perform your ...

About this content About Oliver Haill Oliver has been writing about companies and markets since the early 2000s, cutting his teeth as a financial journalist at Growth Company Investor with a focusing on AIM companies and small caps, before a few years later becoming a section editor and then head of research. He joined Proactive after a couple of years freelancing, where he worked for the Financial Times Group, ITV, Press Association, Reuters sports desk, the London Olympic News Service, Rugby World Cup ...

WEXFORD, Pa., Jan. 22, 2025 /PRNewswire/ -- Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP) (the "Company" or "Coeptis"), a biopharmaceutical company focused on pioneering cell therapy platforms for cancer, autoimmune, and infectious diseases, today announced it has regained compliance with Listing Rule 5550(a)(2) (the "Bid Price Rule"), as required by the Nasdaq Hearings Panel's decision of September 17, 2024."We thank the Nasdaq Hearings Panel for approving our request," said Coeptis' Chief Executive O ...

The Nasdaq Composite has been on a non-stop thrill ride for more than two years and shows no signs of slowing. A number of factors have contributed to the rally, including waning inflation, falling interest rates, higher corporate earnings, and the advent of artificial intelligence (AI). After rising 43% in 2023, the tech-focused index added another 29% in 2024. Those back-to-back gains bode well for the coming year, as history suggests the bull market will continue.Going as far back as far as 1972 -- the f ...